Principia Wealth Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$141K Buy
335
+6
+2% +$2.39K 0.07% 104
2026
Q2
$119K Buy
329
+7
+2% +$2.4K 0.06% 99
2026
Q1
$113K Buy
322
+8
+3% +$2.85K 0.06% 97
2025
Q4
$103K Sell
314
-261
-45% -$82.8K 0.06% 100
2025
Q3
$162K Buy
575
+7
+1% +$2.03K 0.11% 84
2025
Q2
$159K Buy
568
+13
+2% +$3.68K 0.13% 69
2025
Q1
$161K Buy
555
+19
+4% +$5.61K 0.15% 57
2024
Q4
$140K Hold
536
– – 0.13% 57

Other funds holding AMGN

Principia Wealth Advisory's AMGN Position: Q3 2026 in Review

Principia Wealth Advisory increased its Amgen (AMGN) stake by 1.8% in Q3 2026, buying an estimated $2.39K and bringing the position to 335 shares worth $141K. The position accounts for 0.07% of the portfolio, ranked #104.

Principia Wealth Advisory first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $162K in Q3 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Principia Wealth Advisory held 335 shares of Amgen worth $141K as of Q3 2026.
  • Principia Wealth Advisory bought 6 Amgen shares in Q3 2026, an estimated $2.39K.
  • Amgen made up 0.07% of Principia Wealth Advisory's portfolio in Q3 2026, its #104 holding.
  • Principia Wealth Advisory first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • Principia Wealth Advisory's Amgen position peaked at $162K in Q3 2025.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Principia Wealth Advisory's 13F filing for Q3 2026, filed 12 Nov 2026.